Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Koninklijke PhilipsEli Lilly
Last price
€23.90$1,316.72
Currency
EUR
USD
€23B$1.1T
20.4542.66
€1.14$29.79
0.910.45
€0.85$6.69
3.64%0.54%
Sector
HealthHealth
Employees
63,67050,000
Ticker
€PHIA$LLY
Primary listing
AEXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €PHIA or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.